PLK1 anticorps (AA 86-430)
Aperçu rapide pour PLK1 anticorps (AA 86-430) (ABIN4952193)
Antigène
Voir toutes PLK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 86-430
-
Purification
- Antigen affinity
-
Immunogène
- Amino acids 86-430 of human PLK1 were used as the immunogen for the PLK1 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the PLK1 antibody should be determined by the researcher.\. Western blot: 0.1-0.5 μg/mL,IHC (Paraffin): 0.5-1 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Stock
- -20 °C
-
Stockage commentaire
- After reconstitution, the PLK1 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
-
-
- PLK1 (Polo-Like Kinase 1 (PLK1))
-
Autre désignation
- PLK1
-
Sujet
- Serine/threonine-protein kinase PLK1, also known as polo-like kinase 1 (PLK-1) or serine/threonine-protein kinase 13 (STPK13), is an enzyme that in humans is encoded by the PLK1 (polo-like kinase 1) gene. Plk1 is an early trigger for G2/M transition. It supports the functional maturation of the centrosome in late G2/early prophaseand establishment of the bipolar spindle. Also, Plk1 phosphorylates and activates cdc25C, a phosphatase that dephosphorylates and activates the cyclinB/cdc2 complex. Studies have shown that the loss of PLK1 expression can inducepro-apoptotic pathways and inhibit growth. Based on yeast and murine studies of meiosis, human PLK1 may also have a regulatory function in meiosis.
-
UniProt
- P53350
-
Pathways
- Cycle Cellulaire, M Phase
Antigène
-